Literature DB >> 24745834

Role of dehydroepiandrosterone in improving oocyte and embryo quality in IVF cycles.

Rinchen Zangmo1, Neeta Singh2, Sunesh Kumar1, Perumal Vanamail1, Abanish Tiwari1.   

Abstract

The purpose of this study was to evaluate the role of dehydroepiandrosterone (DHEA) on the number and quality of oocytes and embryos in poor responders undergoing IVF cycles. A total of 50 patients with a history of poor ovarian response in the previous cycle(s) were enrolled in a prospective cohort study. They were treated with oral micronized DHEA 25mg three times a day for 4 months. Oocyte and embryo number and quality were recorded before and after treatment. The results were analysed using Student's paired t-test. After treatment with DHEA, a significant increase in number of mature follicles was seen in the post treatment period (⩽ 35 years P<0.001; ⩾ 36 years P = 0.002). There were significant increases in numbers of oocytes retrieved, fertilization rates and, consequently, the total number of embryos available. More embryos were vitrified among patients ⩽ 35 years (P<0.001) post treatment, and clinical pregnancy rate in this group was 26.7%. DHEA treatment resulted in a higher number of oocytes retrieved, oocytes fertilized, embryos overall and of grade-I embryos. It can help in increasing pregnancy rate in poor responders. This study was performed to evaluate the role of dehydroepiandrosterone (DHEA) treatment on the number and quality of oocytes and embryos in poor responders undergoing IVF cycles. Fifty patients with a history of poor ovarian response in the previous cycle(s) were enrolled in the study and a prospective cohort study was performed. Patients were prescribed oral micronized DHEA 25mg three times a day for 4 months. Oocytes and embryos in terms of both number and quality were measured before and after treatment. A significant increase in mean number of mature follicles was seen in the post-treatment group. There was a significant increase in the number of oocytes retrieved, fertilization rates and, consequently, in the total number of embryos available after treatment with DHEA. More embryos were vitrified post treatment and the overall pregnancy rate was 20%. DHEA resulted in a significant improvement in the numbers of oocytes retrieved, oocytes fertilized, embryos and grade-I embryos. DHEA can help improve pregnancy rate in poor responders with history of previous failed IVF cycles.
Copyright © 2014 Reproductive Healthcare Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  dehydroepiandrosterone; embryos; in vitro fertilization; infertility; oocytes; ovarian reserve

Mesh:

Substances:

Year:  2014        PMID: 24745834     DOI: 10.1016/j.rbmo.2014.01.019

Source DB:  PubMed          Journal:  Reprod Biomed Online        ISSN: 1472-6483            Impact factor:   3.828


  10 in total

1.  Lack of effect of short-term DHEA supplementation on the perimenopausal ovary†.

Authors:  Selva L Luna; Donald I Brown; Steven G Kohama; Henryk F Urbanski
Journal:  Biol Reprod       Date:  2020-12-01       Impact factor: 4.285

2.  The effect of medication on serum anti-müllerian hormone (AMH) levels in women of reproductive age: a meta-analysis.

Authors:  Wei-Wei Yin; Chang-Chang Huang; Yi-Ru Chen; Dan-Qing Yu; Min Jin; Chun Feng
Journal:  BMC Endocr Disord       Date:  2022-06-14       Impact factor: 3.263

Review 3.  Dehydroepiandrosterone treatment in women with poor ovarian response undergoing IVF or ICSI: a systematic review and meta-analysis.

Authors:  Meixiang Zhang; Wenbin Niu; Yu Wang; Jiawei Xu; Xiao Bao; Linlin Wang; Linqing Du; Yingpu Sun
Journal:  J Assist Reprod Genet       Date:  2016-04-19       Impact factor: 3.412

Review 4.  Intraovarian control of early folliculogenesis.

Authors:  Aaron J W Hsueh; Kazuhiro Kawamura; Yuan Cheng; Bart C J M Fauser
Journal:  Endocr Rev       Date:  2014-09-09       Impact factor: 19.871

5.  Beta endorphin in serum and follicular fluid of PCOS- and non-PCOS women.

Authors:  Nikolai Jaschke; Fabian Lunger; Ludwig Wildt; Beata Seeber
Journal:  Arch Gynecol Obstet       Date:  2018-05-28       Impact factor: 2.344

6.  Dehydroepiandrosterone Supplementation Improves the Outcomes of in vitro Fertilization Cycles in Older Patients With Diminished Ovarian Reserve.

Authors:  San-Nung Chen; Kuan-Hao Tsui; Peng-Hui Wang; Chyi-Uei Chern; Zhi-Hong Wen; Li-Te Lin
Journal:  Front Endocrinol (Lausanne)       Date:  2019-11-15       Impact factor: 5.555

7.  Ovarian Sensitivity Decreased Significantly in Patients With Insulin Resistance Undergoing in vitro Fertilization and Embryo Transfer.

Authors:  Yanjun Zheng; Ye Pan; Ping Li; Zhongyuan Wang; Ze Wang; Yuhua Shi
Journal:  Front Physiol       Date:  2022-03-11       Impact factor: 4.566

Review 8.  The Role of Androgen Supplementation in Women With Diminished Ovarian Reserve: Time to Randomize, Not Meta-Analyze.

Authors:  Ana Raquel Neves; Pedro Montoya-Botero; Nikolaos P Polyzos
Journal:  Front Endocrinol (Lausanne)       Date:  2021-05-17       Impact factor: 5.555

9.  Dehydroepiandrosterone (DHEA) supplementation improves in vitro fertilization outcomes of poor ovarian responders, especially in women with low serum concentration of DHEA-S: a retrospective cohort study.

Authors:  Chyi-Uei Chern; Kuan-Hao Tsui; Salvatore Giovanni Vitale; San-Nung Chen; Peng-Hui Wang; Antonio Cianci; Hsiao-Wen Tsai; Zhi-Hong Wen; Li-Te Lin
Journal:  Reprod Biol Endocrinol       Date:  2018-09-17       Impact factor: 5.211

10.  The Relationships Between Serum DHEA-S and AMH Levels in Infertile Women: A Retrospective Cross-Sectional Study.

Authors:  Li-Te Lin; Kuan-Hao Tsui
Journal:  J Clin Med       Date:  2021-03-15       Impact factor: 4.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.